Tool Calling and Plugins for siRNA Nucleic Acid Drug

Data Characteristics for this Category

siRNA nucleic acid drug clinical trial data is highly specialized and structured. Data primarily originates from clinical trial registration platforms (e.g., ClinicalTrials.gov), specialized databases (e.g., PDB, DrugBank), pharmaceutical company internal reports, and peer-reviewed journals. Data update frequencies vary; registration platform information may update daily, while specialized databases and journal articles typically update quarterly or annually. Document types are diverse, including trial protocols, case report forms (CRF), investigator brochures (IB), informed consent forms (ICF), and various analysis reports. Data fields cover patient demographics, disease diagnosis, dosing regimens (siRNA sequence, dose, administration route), efficacy indicators (e.g., target gene expression inhibition rate, biomarker levels), and safety assessments (adverse event coding). Units often include mg/kg or nM for dosage. Efficacy indicators may involve log2 fold change, % inhibition, or specific biochemical units.

Constraints on Tool Calling and Plugins from these Characteristics

The specialized nature of siRNA nucleic acid drug data requires highly customized parsing capabilities for tool calling. For example, parsing the siRNA sequence field requires correct identification and extraction of nucleotide sequences, distinguishing modified bases. This demands bioinformatics processing capabilities from plugins. Inconsistent data update frequencies mean tool calling needs to support incremental updates and version control, avoiding reprocessing existing trial data or missing the latest developments. Diverse document structures require plugins to handle various formats (e.g., PDF, XML, JSON) of trial reports and accurately extract key information. Efficacy indicators and safety assessments, in particular, have widely varying field units and value ranges. Tool calling must perform unit conversion and data standardization to ensure accuracy in subsequent analysis. Processing adverse event codes requires mapping to specialized terminologies like MedDRA for standardization.

Configuration Settings

Configuration Item	Recommended Value	Rationale
`maxContext`	`8192`	Clinical trial protocols and reports often contain extensive information, requiring a sufficiently long context window to capture key details.
`PARSE_FILE_TIMEOUT_SECONDS`	`600 seconds`	Parsing large PDF or XML files can be time-consuming; this prevents parsing failures due to timeouts.
`Chunk size` (Segment Length)	`1000–1200 characters`	Balances semantic completeness with model processing efficiency, ensuring each segment contains enough information.
`Recall count` (Recall Count)	`Top 10`	Clinical trial pre-screening requires comprehensive consideration of multiple relevant trials to ensure coverage.
`Similarity threshold` (Similarity Threshold)	`0.78`	For specialized text, increasing the threshold ensures precision of recall results and reduces irrelevant information.
`toolCallTimeout`	`300 seconds`	External tool calls (e.g., sequence alignment, database queries) can be time-consuming; this provides ample time.

Three Common Mistakes

Tool call failure, with logs showing an HTTP 400 error. This occurs when an external API's strict validation of siRNA sequence format fails to correctly process special characters or modification markers.
Model output results show the Adverse Event field as empty or containing non-standardized codes. This happens when the plugin fails to correctly map original data codes to the MedDRA terminology or lacks the corresponding terminology mapping table.
Some trial data is missing from pre-screening results, with logs showing File parse error: document structure mismatch. This occurs when the plugin cannot adapt to non-standard PDF structures of certain trial reports, leading to critical field extraction failures.

How to Confirm Correct Configuration

Select a typical clinical trial report containing complex siRNA sequence and various efficacy indicators. Upload it and check if the parsed data is complete and fields are accurate.
Execute a pre-screening query that includes an external tool call. Check the tool call logs to ensure an HTTP 200 status code and that the returned values conform to the expected data structure.
Randomly select 5-10 pre-screening results. Manually compare their core fields (e.g., dosing regimen, primary endpoint, adverse events) with the original reports to ensure consistency.
Configure an incremental update task. Observe if the system correctly identifies and processes newly published clinical trial data, avoiding duplicate imports or omissions.

The values provided are common starting points and should be measured against the reader's own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.